Skip to contentJ
JRSIS HEALTH CARE Corp
J
JRSSJRSIS HEALTH CARE Corp Q3 2024 · 10-Q
Revenue$222.92K$222.92K−55.2% vs Q3 2023 Net Income-$188.15K-$188.15KN/M vs Q3 2023 EPS Diluted-$0.00-$0.00N/M vs Q3 2023 Gross Profit$26,885−77.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR
Operating Cash Flowderived-$352,266N/M Free Cash Flowderived-$419,899N/M Margins · derivedGross margin12.1%−12.1 pt vs Q3 2023
Operating margin-92.5%−102.8 pt vs Q3 2023
Net margin-84.4%−91.2 pt vs Q3 2023
ended Sep 30, 2024 · filed Dec 20, 2024 · 81 d after period end